skin cancer

Showing 10 posts of 40 posts found.


Roche’s Zelboraf approved by FDA months ahead of schedule

August 18, 2011
Sales and Marketing Yervoy, Zelboraf, skin cancer

The FDA has approved Roche and Daiichi Sankyo’s new skin cancer drug Zelboraf two months ahead of schedule. Zelboraf (vemurafenib) …


Mid-stage trial boost for Roche skin cancer drug vismodegib

June 20, 2011
Research and Development Cancer, Roche, skin cancer, vismodegib

Roche’s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …


Roche impresses at ASCO with vemurafenib

June 6, 2011
Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib

Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …


Roche aims for wholly personalised skin cancer drug

May 12, 2011
Sales and Marketing Roche, personalised medicine, skin cancer, vemurafenib

Roche has submitted its key skin cancer drug vemurafenib to European and American regulators for approval. Vemurafenib (formerly RG7204) has …

Roche's Swiss headquarters

Roche’s skin cancer drug passes mid-stage trial

March 22, 2011
Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib

Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …

GlaxoSmitKline's headquarters

GSK skin cancer drugs moves into phase III

January 25, 2011
Research and Development BRAF V600 mutation, Cancer, Duchenne Muscular Dystrophy, GSK, GSK1120212, GSK2118436, GSK968, GlaxoSmithKline, melanoma, skin cancer

GlaxoSmithKline has begun late-stage trials of two new drugs for advanced or metastatic melanoma patients. GSK2118436 and GSK1120212 are being …

Roche building

Trial success for Roche’s personalised skin cancer drug

January 19, 2011
Research and Development BRAF V600, Cancer, RG7204, Roche, personalised medicine, skin cancer

A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …

Patient deaths halt Lilly cancer trial

December 15, 2010
Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam

Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …

Advanced melanoma

BMS skin cancer drug hits US regulatory delay

November 3, 2010
Research and Development BMS, Bristol-Myers Squibb, FDA, MDX010-020 trial, ipilimumab, skin cancer

US regulators have announced they need more time to assess Bristol-Myers Squibb’s skin cancer treatment ipilimumab. The FDA will not …


Pfizer signs ‘personalised’ cancer collaboration

January 15, 2010
Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab

Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …

Latest content